H.C. Wainwright Maintains SANTHERA PHARMACEUTICALS HOLDING AG(SPHDF.US) With Buy Rating, Raises Target Price to $27.98

Moomoo NewsDec 20 13:31 ET · Ratings

H.C. Wainwright Maintains SANTHERA PHARMACEUTICALS HOLDING AG(SPHDF.US) With Buy Rating, Cuts Target Price to $27.99

Moomoo NewsDec 16 07:31 ET · Ratings

H.C. Wainwright Maintains SANTHERA PHARMACEUTICALS HOLDING AG(SPHDF.US) With Buy Rating, Raises Target Price to $29.72

Moomoo NewsSep 27 06:31 ET · Ratings

H.C. Wainwright Maintains SANTHERA PHARMACEUTICALS HOLDING AG(SPHDF.US) With Buy Rating, Cuts Target Price to $29.57

Moomoo NewsSep 17 06:35 ET · Ratings

Santhera Pharmaceuticals Reports 1H Results

Seeking AlphaSep 13 10:56 ET

Santhera's Shareholders Approve All Board Proposals at Today's Annual General Meeting

Yahoo FinanceJun 18 09:30 ET